Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ilaria Ferrigno"'
Autor:
Francesco Muratore, Carlo Salvarani, Luca Cimino, Luigi Boiardi, Nicolò Pipitone, Stefania Croci, Alessandro Zerbini, Alberto Cavazza, Alessandra Bisagni, Alessandro Rossi, Maria Nicastro, Ilaria Ferrigno, Martina Bonacini, Angelo Ghidini, Giuseppe Malchiodi
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objective To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural inflammation (TMI) and inflammation limited to adve
Externí odkaz:
https://doaj.org/article/6f26fffd2bca4abc9b6b5e0ae0e8465a
Autor:
Anna Sicuranza, Ilaria Ferrigno, Elisabetta Abruzzese, Alessandra Iurlo, Sara Galimberti, Antonella Gozzini, Luigiana Luciano, Fabio Stagno, Antonella Russo Rossi, Nicola Sgherza, Daniele Cattaneo, Corrado Zuanelli Brambilla, Cristina Marzano, Carmen Fava, Olga Mulas, Emanuele Cencini, Adele Santoni, Vincenzo Sammartano, Alessandro Gozzetti, Luca Puccetti, Monica Bocchia
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tyrosine kinase inhibitors (TKI) may offer a normal life expectancy to Chronic Myeloid Leukemia (CML) patients. However, a higher than expected incidence of arterial occlusive events (AOEs) was observed during treatment with nilotinib. We previously
Externí odkaz:
https://doaj.org/article/5ddf4f9f79054a4e8cbdd98e58692599
Autor:
Samantha Sperduti, Silvia Limoncella, Clara Lazzaretti, Elia Paradiso, Laura Riccetti, Sara Turchi, Ilaria Ferrigno, Jessika Bertacchini, Carla Palumbo, Francesco Potì, Salvatore Longobardi, Robert P. Millar, Manuela Simoni, Claire L. Newton, Livio Casarini
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 22, p 5548 (2019)
Commercial gonadotropin-releasing hormone (GnRH) antagonists differ by 1−2 amino acids and are used to inhibit gonadotropin production during assisted reproduction technologies (ART). In this study, potencies of three GnRH antagonists, Cetrorelix,
Externí odkaz:
https://doaj.org/article/76e6bbc3853545dc89f49aead81c58b5
Autor:
Monica Bocchia, Anna Sicuranza, Elisabetta Abruzzese, Alessandra Iurlo, Santina Sirianni, Antonella Gozzini, Sara Galimberti, Lara Aprile, Bruno Martino, Patrizia Pregno, Federica Sorà, Giulia Alunni, Carmen Fava, Fausto Castagnetti, Luca Puccetti, Massimo Breccia, Daniele Cattaneo, Marzia Defina, Olga Mulas, Claudia Baratè, Giovanni Caocci, Simona Sica, Alessandro Gozzetti, Luigiana Luciano, Monica Crugnola, Mario Annunziata, Mario Tiribelli, Paola Pacelli, Ilaria Ferrigno, Emilio Usala, Nicola Sgherza, Gianantonio Rosti, Alberto Bosi, Donatella Raspadori
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Chronic myeloid leukemia (CML) patients in sustained “deep molecular response” may stop TKI treatment without disease recurrence; however, half of them lose molecular response shortly after TKI withdrawing. Well-defined eligibility criteria to pr
Externí odkaz:
https://doaj.org/article/88672560f3b64e7bab3c3e74f698361b
Autor:
Martina Bonacini, Alessandro Rossi, Ilaria Ferrigno, Francesco Muratore, Carlo Salvarani, Stefania Croci
Publikováno v:
Clinical and Experimental Rheumatology.
Autor:
Pier Luigi Meroni, Stefania Croci, Paola Adele Lonati, Francesca Pregnolato, Lucia Spaggiari, Giulia Besutti, Martina Bonacini, Ilaria Ferrigno, Alessandro Rossi, Geir Hetland, Ivana Hollan, Massimo Cugno, Francesco Tedesco, Maria Orietta Borghi, Carlo Salvarani
Coronavirus disease 19 (COVID-19) may present as a multi-organ disease with a hyperinflammatory and prothrombotic response (immunothrombosis) in addition to upper and lower airway involvement. Previous data showed that complement activation plays a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500a0b147274a653890f5c1e7d02268d
https://hdl.handle.net/11380/1295655
https://hdl.handle.net/11380/1295655
Minimal Residual Disease in Multiple Myeloma: State of the Art and Applications in Clinical Practice
Autor:
Dania Tocci, Monica Bocchia, Donatella Raspadori, Ilaria Ferrigno, Anna Sicuranza, Paola Pacelli, Alessandro Gozzetti, Francesca Bacchiarri
Publikováno v:
Journal of Personalized Medicine, Vol 10, Iss 120, p 120 (2020)
Journal of Personalized Medicine
Journal of Personalized Medicine
Novel drugs have revolutionized multiple myeloma therapy in the last 20 years, with median survival that has doubled to up to 8–10 years. The introduction of therapeutic strategies, such as consolidation and maintenance after autologous stem cell t
Autor:
Monica Bocchia, Anna Sicuranza, Elisabetta Abruzzese, Antonella Russo Rossi, Daniele Cattaneo, Emanuele Cencini, Corrado Zuanelli Brambilla, Cristina Marzano, Carmen Fava, Fabio Stagno, Luca Puccetti, Olga Mulas, Ilaria Ferrigno, Sara Galimberti, Antonella Gozzini, Nicola Sgherza, Alessandro Gozzetti, Luigiana Luciano, Alessandra Iurlo
Publikováno v:
Blood. 138:1479-1479
Background: Tyrosine kinase inhibitors (TKI) may offer a normal life expectancy to Chronic Myeloid Leukemia (CML) patients. However, during treatment with nilotinib, a higher than expected incidence of arterial occlusive events (AOEs) was observed. W
Autor:
Livio Casarini, Claire L. Newton, Manuela Simoni, Clara Lazzaretti, Robert P. Millar, Ilaria Ferrigno, Samantha Sperduti, Francesco Potì, Carla Palumbo, Salvatore Longobardi, Laura Riccetti, Elia Paradiso, Jessika Bertacchini, Sara Turchi, Silvia Limoncella
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, MDPI, 2019, 20 (22), pp.5548. ⟨10.3390/ijms20225548⟩
International Journal of Molecular Sciences, Vol 20, Iss 22, p 5548 (2019)
International Journal of Molecular Sciences 22 (20), . (2019)
Volume 20
Issue 22
International Journal of Molecular Sciences, MDPI, 2019, 20 (22), pp.5548. ⟨10.3390/ijms20225548⟩
International Journal of Molecular Sciences, Vol 20, Iss 22, p 5548 (2019)
International Journal of Molecular Sciences 22 (20), . (2019)
Volume 20
Issue 22
Commercial gonadotropin-releasing hormone (GnRH) antagonists differ by 1&ndash
2 amino acids and are used to inhibit gonadotropin production during assisted reproduction technologies (ART). In this study, potencies of three GnRH antagonists, Cet
2 amino acids and are used to inhibit gonadotropin production during assisted reproduction technologies (ART). In this study, potencies of three GnRH antagonists, Cet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebe8bf1a95a2813ce5c40fcc64fec10d
https://hal.archives-ouvertes.fr/hal-02501225
https://hal.archives-ouvertes.fr/hal-02501225
Autor:
Anna Sicuranza, Ilaria Ferrigno, Patrizia Pregno, Marzia Defina, Monica Crugnola, Paola Pacelli, Anna Marina Liberati, Sara Ciofini, Sara Galimberti, Luigiana Luciano, Luca Puccetti, Donatella Raspadori, Federica Sorà, Monica Bocchia, Mario Annunziata, Elisabetta Abruzzese, Alessandra Iurlo
Publikováno v:
Blood. 134:2919-2919
Background and rationale In chronic myeloid leukemia (CML) about half of patients (pts) achieving a deep and stable molecular response (MR) with tyrosine kinase inhibitors (TKIs) may discontinue TKI treatment without disease recurrence. As such, trea